These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 29736698

  • 1. Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.
    Nestor PJ, Altomare D, Festari C, Drzezga A, Rivolta J, Walker Z, Bouwman F, Orini S, Law I, Agosta F, Arbizu J, Boccardi M, Nobili F, Frisoni GB, EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1509-1525. PubMed ID: 29736698
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluating 2-[18F]FDG-PET in differential diagnosis of dementia using a data-driven decision model.
    Gjerum L, Frederiksen KS, Henriksen OM, Law I, Bruun M, Simonsen AH, Mecocci P, Baroni M, Dottorini ME, Koikkalainen J, Lötjönen J, Hasselbalch SG.
    Neuroimage Clin; 2020 Jul; 27():102267. PubMed ID: 32417727
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y, Iseki E, Fujishiro H, Ota K, Kasanuki K, Suzuki M, Hirayasu Y, Arai H, Sato K.
    Psychiatry Res Neuroimaging; 2016 Mar 30; 249():105-12. PubMed ID: 26857415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Brain 18 F-FDG-PET and an optimized cingulate island ratio to differentiate Lewy body dementia and Alzheimer's disease.
    Woyk K, Sahlmann CO, Hansen N, Timäus C, Müller SJ, Khadhraoui E, Wiltfang J, Lange C, Bouter C.
    J Neuroimaging; 2023 Mar 30; 33(2):256-268. PubMed ID: 36465027
    [Abstract] [Full Text] [Related]

  • 9. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS, Hellwig S, Amtage F, Weiller C, Bormann T, Weber WA, Hüll M, Meyer PT, Frings L.
    J Neuroimaging; 2015 Mar 30; 25(2):281-288. PubMed ID: 24593796
    [Abstract] [Full Text] [Related]

  • 10. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C, Della Rosa PA, Magnani G, Santangelo R, Marcone A, Cappa SF, Perani D.
    Neuroimage Clin; 2015 Mar 30; 7():187-94. PubMed ID: 25610780
    [Abstract] [Full Text] [Related]

  • 11. Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration.
    Duignan JA, Haughey A, Kinsella JA, Killeen RP.
    Semin Nucl Med; 2021 May 30; 51(3):264-274. PubMed ID: 33402272
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
    Ishiki A, Kamada M, Kawamura Y, Terao C, Shimoda F, Tomita N, Arai H, Furukawa K.
    J Neurochem; 2016 Jan 30; 136(2):258-61. PubMed ID: 26485083
    [Abstract] [Full Text] [Related]

  • 14. Brain fluorodeoxyglucose (FDG) PET in dementia.
    Kato T, Inui Y, Nakamura A, Ito K.
    Ageing Res Rev; 2016 Sep 30; 30():73-84. PubMed ID: 26876244
    [Abstract] [Full Text] [Related]

  • 15. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.
    Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappatà S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L, EADC-PET Consortium.
    Neuroimage Clin; 2014 Sep 30; 6():445-54. PubMed ID: 25389519
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K.
    Exp Neurol; 2005 Feb 30; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Spatial covariance analysis of FDG-PET and HMPAO-SPECT for the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease.
    Ingram M, Colloby SJ, Firbank MJ, Lloyd JJ, O'Brien JT, Taylor JP.
    Psychiatry Res Neuroimaging; 2022 Jun 30; 322():111460. PubMed ID: 35247828
    [Abstract] [Full Text] [Related]

  • 20. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
    Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S.
    Brain; 2007 Oct 30; 130(Pt 10):2616-35. PubMed ID: 17704526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.